5-83538811-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004385.5(VCAN):​c.5808T>C​(p.Gly1936Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.485 in 1,613,530 control chromosomes in the GnomAD database, including 190,969 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.50 ( 19150 hom., cov: 32)
Exomes 𝑓: 0.48 ( 171819 hom. )

Consequence

VCAN
NM_004385.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.0340

Publications

22 publications found
Variant links:
Genes affected
VCAN (HGNC:2464): (versican) This gene is a member of the aggrecan/versican proteoglycan family. The protein encoded is a large chondroitin sulfate proteoglycan and is a major component of the extracellular matrix. This protein is involved in cell adhesion, proliferation, proliferation, migration and angiogenesis and plays a central role in tissue morphogenesis and maintenance. Mutations in this gene are the cause of Wagner syndrome type 1. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2009]
VCAN-AS1 (HGNC:40163): (VCAN antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 5-83538811-T-C is Benign according to our data. Variant chr5-83538811-T-C is described in ClinVar as Benign. ClinVar VariationId is 167824.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.034 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.517 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VCANNM_004385.5 linkc.5808T>C p.Gly1936Gly synonymous_variant Exon 8 of 15 ENST00000265077.8 NP_004376.2 P13611-1A0A024RAQ9Q59FG9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VCANENST00000265077.8 linkc.5808T>C p.Gly1936Gly synonymous_variant Exon 8 of 15 1 NM_004385.5 ENSP00000265077.3 P13611-1

Frequencies

GnomAD3 genomes
AF:
0.501
AC:
76012
AN:
151836
Hom.:
19137
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.507
Gnomad AMI
AF:
0.680
Gnomad AMR
AF:
0.526
Gnomad ASJ
AF:
0.583
Gnomad EAS
AF:
0.410
Gnomad SAS
AF:
0.393
Gnomad FIN
AF:
0.529
Gnomad MID
AF:
0.500
Gnomad NFE
AF:
0.494
Gnomad OTH
AF:
0.536
GnomAD2 exomes
AF:
0.485
AC:
121638
AN:
250688
AF XY:
0.479
show subpopulations
Gnomad AFR exome
AF:
0.506
Gnomad AMR exome
AF:
0.520
Gnomad ASJ exome
AF:
0.576
Gnomad EAS exome
AF:
0.398
Gnomad FIN exome
AF:
0.513
Gnomad NFE exome
AF:
0.499
Gnomad OTH exome
AF:
0.495
GnomAD4 exome
AF:
0.484
AC:
707184
AN:
1461576
Hom.:
171819
Cov.:
72
AF XY:
0.481
AC XY:
349669
AN XY:
727102
show subpopulations
African (AFR)
AF:
0.499
AC:
16716
AN:
33476
American (AMR)
AF:
0.519
AC:
23176
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.575
AC:
15018
AN:
26132
East Asian (EAS)
AF:
0.463
AC:
18384
AN:
39696
South Asian (SAS)
AF:
0.388
AC:
33471
AN:
86258
European-Finnish (FIN)
AF:
0.508
AC:
27036
AN:
53246
Middle Eastern (MID)
AF:
0.502
AC:
2897
AN:
5768
European-Non Finnish (NFE)
AF:
0.487
AC:
541479
AN:
1111914
Other (OTH)
AF:
0.480
AC:
29007
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
26504
53008
79511
106015
132519
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15876
31752
47628
63504
79380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.501
AC:
76059
AN:
151954
Hom.:
19150
Cov.:
32
AF XY:
0.500
AC XY:
37117
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.507
AC:
21007
AN:
41466
American (AMR)
AF:
0.526
AC:
8031
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.583
AC:
2021
AN:
3468
East Asian (EAS)
AF:
0.410
AC:
2110
AN:
5148
South Asian (SAS)
AF:
0.391
AC:
1883
AN:
4814
European-Finnish (FIN)
AF:
0.529
AC:
5579
AN:
10542
Middle Eastern (MID)
AF:
0.497
AC:
146
AN:
294
European-Non Finnish (NFE)
AF:
0.494
AC:
33530
AN:
67938
Other (OTH)
AF:
0.536
AC:
1133
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1959
3917
5876
7834
9793
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
674
1348
2022
2696
3370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.503
Hom.:
29336
Bravo
AF:
0.499
Asia WGS
AF:
0.412
AC:
1431
AN:
3478
EpiCase
AF:
0.502
EpiControl
AF:
0.503

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Wagner syndrome Benign:3
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Jan 20, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 05, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Vitreoretinopathy Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.60
CADD
Benign
6.7
DANN
Benign
0.83
PhyloP100
0.034
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs309557; hg19: chr5-82834630; COSMIC: COSV54100112; COSMIC: COSV54100112; API